Synta names new corporate development VP
This article was originally published in Scrip
Executive Summary
Synta Pharmaceuticals, a biopharmaceutical company developing and commercializing small molecule drugs for conditions including cancer and chronic inflammatory diseases, has named Steven Bernitz senior vice-president of corporate development. Prior to joining the Lexington, Massachusetts-based firm, Mr Bernitz was a general partner and head of the BioPharm practice at Extera Partners, a business development advisory firm.